Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Hogarth

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Social Science & Medicine (1982)|February 10, 2015
Neoliberal technocracy: explaining how and why the US Food and Drug Administration has championed pharmacogenomicsStuart Hogarth
The Lancet. Oncology|March 5, 2013
Genes, genes, genesStuart Hogarth, Richard Sullivan
Social Science & Medicine (1982)|September 27, 2020
Regulatory niches: Diagnostic reform as a process of fragmented expansion. Evidence from the UK 1990-2018Stuart Hogarth, Olga Löblová
Regenerative Medicine|November 19, 2010
Regenerative medicine in Europe: global competition and innovation governanceStuart Hogarth, Brian Salter
Nature Biotechnology|June 9, 2012
Biomarker patents for diagnostics: problem or solution?Michael M Hopkins, Stuart Hogarth
Personalized Medicine|May 16, 2018
Personalized medicine: renewing the social science research agendaStuart Hogarth, Michael Hopkins, Alex Faulkner
Annual Review of Genomics and Human Genetics|September 5, 2008
The current landscape for direct-to-consumer genetic testing: legal, ethical, and policy issuesStuart Hogarth, Gail Javitt, David Melzer
Sociology of Health & Illness|November 29, 2011
A molecular monopoly? HPV testing, the Pap smear and the molecularisation of cervical cancer screening in the USAStuart Hogarth, Michael M Hopkins, Victor Rodriguez
Social Science & Medicine (1982)|June 17, 2022
Multidisciplinary perspectives on the regulation of diagnostic technologiesStuart Hogarth, Fiona A Miller, Steve Sturdy
Plos One|April 27, 2023
Industry involvement in evidence production for genomic medicine: A bibliometric and funding analysis of decision impact studiesGillian Parker, Sarah Hunter, Stuart Hogarth, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Social Science & Medicine (1982)|February 10, 2015
Neoliberal technocracy: explaining how and why the US Food and Drug Administration has championed pharmacogenomicsStuart Hogarth
The Lancet. Oncology|March 5, 2013
Genes, genes, genesStuart Hogarth, Richard Sullivan
Social Science & Medicine (1982)|September 27, 2020
Regulatory niches: Diagnostic reform as a process of fragmented expansion. Evidence from the UK 1990-2018Stuart Hogarth, Olga Löblová
Regenerative Medicine|November 19, 2010
Regenerative medicine in Europe: global competition and innovation governanceStuart Hogarth, Brian Salter
Nature Biotechnology|June 9, 2012
Biomarker patents for diagnostics: problem or solution?Michael M Hopkins, Stuart Hogarth
Personalized Medicine|May 16, 2018
Personalized medicine: renewing the social science research agendaStuart Hogarth, Michael Hopkins, Alex Faulkner
Annual Review of Genomics and Human Genetics|September 5, 2008
The current landscape for direct-to-consumer genetic testing: legal, ethical, and policy issuesStuart Hogarth, Gail Javitt, David Melzer
Sociology of Health & Illness|November 29, 2011
A molecular monopoly? HPV testing, the Pap smear and the molecularisation of cervical cancer screening in the USAStuart Hogarth, Michael M Hopkins, Victor Rodriguez
Social Science & Medicine (1982)|June 17, 2022
Multidisciplinary perspectives on the regulation of diagnostic technologiesStuart Hogarth, Fiona A Miller, Steve Sturdy
Plos One|April 27, 2023
Industry involvement in evidence production for genomic medicine: A bibliometric and funding analysis of decision impact studiesGillian Parker, Sarah Hunter, Stuart Hogarth, et al.
Pageof 3